BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1574 related articles for article (PubMed ID: 25788262)

  • 21. CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling.
    Tseng JC; Lin CY; Su LC; Fu HH; Yang SD; Chuu CP
    Oncotarget; 2016 Jun; 7(25):38010-38024. PubMed ID: 27191743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caffeic acid phenethyl ester induces apoptosis by inhibition of NFkappaB and activation of Fas in human breast cancer MCF-7 cells.
    Watabe M; Hishikawa K; Takayanagi A; Shimizu N; Nakaki T
    J Biol Chem; 2004 Feb; 279(7):6017-26. PubMed ID: 14625298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholestane-3β, 5α, 6β-triol suppresses proliferation, migration, and invasion of human prostate cancer cells.
    Lin CY; Huo C; Kuo LK; Hiipakka RA; Jones RB; Lin HP; Hung Y; Su LC; Tseng JC; Kuo YY; Wang YL; Fukui Y; Kao YH; Kokontis JM; Yeh CC; Chen L; Yang SD; Fu HH; Chen YW; Tsai KK; Chang JY; Chuu CP
    PLoS One; 2013; 8(6):e65734. PubMed ID: 23785446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination treatment of docetaxel with caffeic acid phenethyl ester suppresses the survival and the proliferation of docetaxel-resistant prostate cancer cells via induction of apoptosis and metabolism interference.
    Fu YK; Wang BJ; Tseng JC; Huang SH; Lin CY; Kuo YY; Hour TC; Chuu CP
    J Biomed Sci; 2022 Feb; 29(1):16. PubMed ID: 35197069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks.
    Chuu CP; Lin HP; Ciaccio MF; Kokontis JM; Hause RJ; Hiipakka RA; Liao S; Jones RB
    Cancer Prev Res (Phila); 2012 May; 5(5):788-97. PubMed ID: 22562408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nobiletin downregulates the SKP2-p21/p27-CDK2 axis to inhibit tumor progression and shows synergistic effects with palbociclib on renal cell carcinoma.
    Chen T; Liu L; Zou Y; Hu X; Zhang W; Zhou T; Luo X; Fu W; Xu J
    Cancer Biol Med; 2021 Feb; 18(1):227-244. PubMed ID: 33628597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2.
    Koo KH; Kim H; Bae YK; Kim K; Park BK; Lee CH; Kim YN
    Cell Death Dis; 2013 Jun; 4(6):e693. PubMed ID: 23807222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
    Kokontis JM; Hay N; Liao S
    Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Penta-O-galloyl-beta-D-glucose induces G1 arrest and DNA replicative S-phase arrest independently of cyclin-dependent kinase inhibitor 1A, cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple negative xenograft growth.
    Chai Y; Lee HJ; Shaik AA; Nkhata K; Xing C; Zhang J; Jeong SJ; Kim SH; Lu J
    Breast Cancer Res; 2010; 12(5):R67. PubMed ID: 20809980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function.
    Liu S; Yamauchi H
    Cancer Lett; 2009 Dec; 286(2):240-9. PubMed ID: 19631451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells.
    Cariaga-Martinez AE; López-Ruiz P; Nombela-Blanco MP; Motiño O; González-Corpas A; Rodriguez-Ubreva J; Lobo MV; Cortés MA; Colás B
    Cell Signal; 2013 Jul; 25(7):1586-97. PubMed ID: 23567263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals.
    Xie H; Li C; Dang Q; Chang LS; Li L
    Oncotarget; 2016 Jan; 7(2):1341-53. PubMed ID: 26625310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cells.
    Gulappa T; Reddy RS; Suman S; Nyakeriga AM; Damodaran C
    Cancer Lett; 2013 Sep; 337(2):177-83. PubMed ID: 23684928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
    Tsihlias J; Zhang W; Bhattacharya N; Flanagan M; Klotz L; Slingerland J
    Oncogene; 2000 Feb; 19(5):670-9. PubMed ID: 10698512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.
    Chuu CP; Kokontis JM; Hiipakka RA; Fukuchi J; Lin HP; Lin CY; Huo C; Su LC; Liao S
    Cancer Sci; 2011 Nov; 102(11):2022-8. PubMed ID: 21781227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
    Fang L; Wang H; Zhou L; Yu D
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caffeic acid phenethyl ester induces E2F-1-mediated growth inhibition and cell-cycle arrest in human cervical cancer cells.
    Hsu TH; Chu CC; Hung MW; Lee HJ; Hsu HJ; Chang TC
    FEBS J; 2013 Jun; 280(11):2581-93. PubMed ID: 23497083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vorinostat enhances protein stability of p27 and p21 through negative regulation of Skp2 and Cks1 in human breast cancer cells.
    Uehara N; Yoshizawa K; Tsubura A
    Oncol Rep; 2012 Jul; 28(1):105-10. PubMed ID: 22484732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses prostate cancer without adverse effect.
    Etani T; Suzuki T; Naiki T; Naiki-Ito A; Ando R; Iida K; Kawai N; Tozawa K; Miyata N; Kohri K; Takahashi S
    Oncotarget; 2015 Feb; 6(5):2865-78. PubMed ID: 25605246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 79.